文献速递主动脉疾病

开窗腔内修复挽救失败腹主动脉瘤修复的长期结果

Salvage of Failing Abdominal Aortic Aneurysm Repairs with Fenestrated Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2025-08-14

该回顾性研究比较了Zenith开窗平台下初次开窗腔内修复(FEVAR)与挽救性再干预FEVAR(RFEVAR)的结局。153例患者中20例RFEVAR,指征为近端病变进展(55%)和IA型内漏(45%)。RFEVAR技术成功率95.0%,60个月生存率和免于再干预率与初次修复无差异。

要点

  • RFEVAR技术成功率95.0%,与初次FEVAR的97.7%无显著差异(P=0.43)。
  • RFEVAR组60个月估计生存率68.8%,免于再干预率76.0%,与初次修复相当。
  • RFEVAR手术时间和支架内脏动脉数量多于初次FEVAR,但长期结局可比。

核心结论

  • 使用ZFEN平台的RFEVAR可有效挽救失败的腹主动脉瘤修复,60个月结局与初次FEVAR相当。
  • RFEVAR避免了传统开放手术的显著并发症,支持ZFEN用于挽救主动脉修复的长期有效性。

研究设计与样本

  • 回顾性综述,纳入2012年1月至2019年8月单中心所有FEVAR病例,比较初次FEVAR与挽救性RFEVAR,随访60个月。
  • 共153例患者,初次FEVAR 133例,RFEVAR 20例;主要结局为技术成功,次要结局包括死亡率、再干预和并发症。

主要发现

  • RFEVAR指征包括近端病变进展(55%)和IA型内漏(45%)。
  • 初次FEVAR手术时间更短(217.6 vs. 265.6分钟,P=0.018),支架内脏动脉数量更少(2.2 vs. 2.6,P=0.021)。
  • 技术成功率初次FEVAR 97.7%,RFEVAR 95.0%(P=0.43)。
  • 60个月时两组估计生存率(P=0.38)和免于再干预率(P=0.80)无差异,RFEVAR组分别为68.8%和76.0%。

临床怎么用

  • 对于既往腹主动脉瘤修复失败且适合腔内治疗的患者,可考虑使用ZFEN行RFEVAR作为开放手术的替代方案。
  • RFEVAR手术复杂度和内脏动脉支架数量可能高于初次FEVAR,但长期结局相似。

局限性

  • 回顾性单中心研究,RFEVAR样本量较小(20例),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fenestrated endovascular aortic repair (FEVAR) can be used for salvage of failing abdominal aortic aneurysm (AAA) repairs. We describe our experience with the commercially available Zenith fenestrated (ZFEN) platform to salvage failing AAA repairs. METHODS: This is a retrospective review of all FEVARs performed from January 2012 until August 2019 at a tertiary academic medical center. The study compared primary FEVAR against reoperative FEVARs (RFEVAR) done for salvage of prior infrarenal aneurysm repairs with 60 months of follow-up. The primary outcome was technical success. Secondary outcomes included mortality, reintervention, and complications. RESULTS: There were 153 patients meeting inclusion criteria, with 133 primary repairs and 20 RFEVARs. Indications for repair included proximal disease progression (55%) and type IA endoleak (45%). Primary FEVARs were associated with decreased case complexity, with shorter operative time (217.6 vs. 265.6 minutes, P = 0.018) and number of visceral arteries stented (2.2 vs. 2.6, P = 0.021). Technical success was 97.7% in the primary FEVAR group, versus 95.0% in the RFEVAR group (P = 0.43). At 60 months, estimated survival and freedom from reintervention did not differ between groups and were 68.8% (P = 0.38) and 76.0% (P = 0.80), respectively, in the RFEVAR group. CONCLUSION: RFEVAR using ZFEN is effective to salvage failing AAA repairs, with 60-month outcomes comparable to primary repair of AAA using FEVAR. RFEVAR is attractive over traditional open approaches as it avoids significant morbidity. These results support the long-term efficacy of ZFEN to salvage failing aortic repairs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Basu R, Davis J, Madison M, et al. Salvage of Failing Abdominal Aortic Aneurysm Repairs with Fenestrated Endovascular Aortic Repair. Ann Vasc Surg. 2025. PMID: 40818817. doi:10.1016/j.avsg.2025.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。